48 related articles for article (PubMed ID: 7365253)
1. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
Sone S; Poste G; Fidler IJ
J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
[TBL] [Abstract][Full Text] [Related]
2. Muramyl Tripeptide-Phosphatidyl Ethanolamine Encapsulated in Liposomes (L-MTP-PE) in the Treatment of Osteosarcoma.
Meyers PA
Adv Exp Med Biol; 2020; 1257():133-139. PubMed ID: 32483736
[TBL] [Abstract][Full Text] [Related]
3. Particle-mediated delivery of cytokines for immunotherapy.
Christian DA; Hunter CA
Immunotherapy; 2012 Apr; 4(4):425-41. PubMed ID: 22512636
[TBL] [Abstract][Full Text] [Related]
4. Effect of liposome-encapsulation on immunomodulating and antiviral activities of interferon-gamma 1.
Saravolac EG; Kournikakis B; Gorton L; Wong JP
Antiviral Res; 1996 Mar; 29(2-3):199-207. PubMed ID: 8739599
[TBL] [Abstract][Full Text] [Related]
5. Kinetics and ultrastructural studies of the induction of rat alveolar macrophage fusion by mediators released from mitogen-stimulated lymphocytes.
Sone S; Bucana C; Hoyer LC; Fidler IJ
Am J Pathol; 1981 May; 103(2):234-46. PubMed ID: 7234965
[TBL] [Abstract][Full Text] [Related]
6. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.
Fidler IJ; Sone S; Fogler WE; Barnes ZL
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1680-4. PubMed ID: 6940181
[TBL] [Abstract][Full Text] [Related]
7. In vitro growth characteristics associated with benign and metastatic variants of tumor cells.
Cifone MA
Cancer Metastasis Rev; 1982; 1(4):335-47. PubMed ID: 6764379
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.
Fidler IJ; Poste G
Springer Semin Immunopathol; 1982; 5(2):161-74. PubMed ID: 6755782
[No Abstract] [Full Text] [Related]
9. Stimulatory effect of vitamin A on tumoricidal activity of rat alveolar macrophages.
Tachibana K; Sone S; Tsubura E; Kishino Y
Br J Cancer; 1984 Mar; 49(3):343-8. PubMed ID: 6704311
[TBL] [Abstract][Full Text] [Related]
10. Activation and fusion induced by 1 alpha,25-dihydroxyvitamin D3 and their relation in alveolar macrophages.
Abe E; Shiina Y; Miyaura C; Tanaka H; Hayashi T; Kanegasaki S; Saito M; Nishii Y; DeLuca HF; Suda T
Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7112-6. PubMed ID: 6594685
[TBL] [Abstract][Full Text] [Related]
11. Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state.
Sone S; Mutsuura S; Ogawara M; Utsugi T; Tsubura E
Cancer Immunol Immunother; 1984; 18(3):169-73. PubMed ID: 6568873
[TBL] [Abstract][Full Text] [Related]
12. Lysis of herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma.
Koff WC; Showalter SD; Seniff DA; Hampar B
Infect Immun; 1983 Dec; 42(3):1067-72. PubMed ID: 6358037
[TBL] [Abstract][Full Text] [Related]
13. Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.
Kleinerman ES; Schroit AJ; Fogler WE; Fidler IJ
J Clin Invest; 1983 Jul; 72(1):304-15. PubMed ID: 6348087
[TBL] [Abstract][Full Text] [Related]
14. Immunology of metastasis. Can the immune response cope with disseminated tumor?
Frost P; Kerbel RS
Cancer Metastasis Rev; 1983; 2(3):239-56. PubMed ID: 6231096
[TBL] [Abstract][Full Text] [Related]
15. Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi.
Brummer E; Morrison CJ; Stevens DA
Infect Immun; 1985 Sep; 49(3):724-30. PubMed ID: 3928493
[TBL] [Abstract][Full Text] [Related]
16. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
Robinson BW; McLemore TL; Crystal RG
J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
[TBL] [Abstract][Full Text] [Related]
17. A dried preparation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor state.
Sone S; Utsugi T; Tandon P; Ogawara M
Cancer Immunol Immunother; 1986; 22(3):191-6. PubMed ID: 3731204
[TBL] [Abstract][Full Text] [Related]
18. Optimization and limitations of systemic treatment of murine melanoma metastases with liposomes containing muramyl tripeptide phosphatidylethanolamine.
Fidler IJ
Cancer Immunol Immunother; 1986; 21(3):169-73. PubMed ID: 3698058
[TBL] [Abstract][Full Text] [Related]
19. Effects of immunopotentiating agents on alveolar macrophage properties.
Charley B
Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):155-9. PubMed ID: 3539492
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
